Skip to main content
Figure 1 | BMC Cardiovascular Disorders

Figure 1

From: Reduction of post injury neointima formation due to 17β-estradiol and phytoestrogen treatment is not influenced by the pure synthetic estrogen receptor antagonist ICI 182,780 in vitro

Figure 1

Inhibitory effect of 17β-estradiol (E), genistein (G) and daidzein (D) on post-injury neointima development in concentrations of 20/30/40 μM, compared to endothelium balloon denuded (BD) controls (C) (mean ± SD). The medium of all groups contained 1 % isopropanol (1 % iso) and 1 % DMSO. Compared with controls 17β-estradiol, genistein, and daidzein (*) reduced neointima formation significantly (p = 0.05) in a concentration dependent manner. Data from Finking et al., 2000 [25].

Back to article page